Depression care and prevalence in HIV-positive individuals

References

• Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–254.
   PubMed Web of Science ®Google Scholar
• Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–728.
   PubMed Web of Science ®Google Scholar
• Orlando M, Burnam MA, Beckman R, et al. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2002;11:75–82.
   PubMed Web of Science ®Google Scholar
• Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158: 725–730.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol. 2000;183:759–769.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Services; 2005.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). HIV prevalence estimates – United States, 2006. Morb Mortal Wkly Rep. 2008;57: 1073–1076.
   Google Scholar
• McQuaid JR, Stein MB, Laffaye C, McCahill ME. Depression in a primary care clinic: the prevalence and impact of an unrecognized disorder. J Affect Disord. 1999;55:1–10.
   PubMed Web of Science ®Google Scholar
• Asch SM, Kilbourne AM, Gifford AL, et al. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18:450–460.
   PubMed Web of Science ®Google Scholar
• Pyne JM, Asch SM, Lincourt K, et al. Quality indicators for depression care in HIV patients. AIDS Care. 2008;20:1075–1083.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000;188:662–670.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Heckman T, Kochman A, Sikkema K, Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv. 2000;51:903–907.
   PubMed Web of Science ®Google Scholar
• Carrico AW, Johnson MO, Morin SF, et al. Correlates of suicidal ideation among HIV-positive persons. AIDS. 2007;21:1199–1203.
   PubMed Web of Science ®Google Scholar
• Gliatto MF, Rai AK. Evaluation and treatment of patients with suicidal ideation. Am Fam Physician. 1999;59:1500–1506.
   PubMed Web of Science ®Google Scholar
• Suicide Prevention Resource Center [homepage on the Internet]. Newton, MA: Education Development Center Inc.; c1994–2009. Available from: http://www.sprc.org/. Accessed 2010.
   Google Scholar
• Ownby RL, Kumar AM, Benny FJ, et al. Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users. J Neuroimmune Pharmacol. 2009;4:350–358.
   Web of Science ®Google Scholar
• Decrion AZ, Dichamp I, Varin A, Herbein G. HIV and inflammation. Current HIV Research. 2005;3:243–259.
   PubMed Web of Science ®Google Scholar
• Henry K, Kitch D, Dube M, et al. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s. AIDS. 2004;18:2434–2437.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Hyman SE, Malenka RC. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. 2nd ed. New York: McGraw-Hill; 2009.
   Google Scholar
• Gimeno D, Kivimaki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39:413–423.
   PubMed Web of Science ®Google Scholar
• Wagner G, Rabkin J, Rabkin R. Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV+ men. Med Sci Sports Exerc. 1998;30:811–817.
   PubMed Web of Science ®Google Scholar
• Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 2007;30:464–472.
   PubMed Web of Science ®Google Scholar
• Ownby RL. Neuroinflammation and cognitive aging. Curr Psychiatry Rep. 2010;12:39–45.
   PubMed Web of Science ®Google Scholar
• Ances BM, Letendre SL, Alexander T, Ellis RJ. Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders. Int Rev Psychiatry. 2008;20:89–93.
   PubMed Web of Science ®Google Scholar
• Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol. 2005;64:529–536.
   PubMed Web of Science ®Google Scholar
• Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384–390.
   PubMed Web of Science ®Google Scholar
• Anthony IC, Arango JC, Stephens B, Simmonds P, Bell JE. The effects of illicit drugs on the HIV infected brain. Front Biosci. 2008;13: 1294–1307.
   PubMed Web of Science ®Google Scholar
• Gualtieri CT, Johnson LG, Benedict KB. Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci. 2006;18:217–225.
   PubMed Web of Science ®Google Scholar
• McClintock SM, Husain MM, Greer TL, Cullum CM. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology. 2010;24:9–34.
   PubMed Web of Science ®Google Scholar
• Cysique LA, Deutsch R, Atkinson JH, et al. Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc. 2007;13:1–11.
   PubMed Web of Science ®Google Scholar
• Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res. 2002;53:647–654.
   PubMed Web of Science ®Google Scholar
• Sadek JR, Vigil O, Grant I, Heaton RK; for the HNRC Group. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol. 2007;29:266–276.
   Google Scholar
• Waldrop-Valverde D, Ownby RL, Kumar M. Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users. Psychiatry Clin Neurosci. 2005;59:372–378.
   PubMed Web of Science ®Google Scholar
• Applebaum AJ, Otto MW, Richardson MA, Safren SA. Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. J Clin Exp Neuropsychol. 2009 Nov 4; 1–11.
   Web of Science ®Google Scholar
• Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45: 394–402.
   PubMed Web of Science ®Google Scholar
• Waldrop-Valverde D, Valverde E. Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care STDS. 2005;19:326–334.
   PubMed Web of Science ®Google Scholar
• Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr. 2010;53:266–272.
   PubMed Web of Science ®Google Scholar
• Evans D, Petitto J, Leserman J, et al. Stress, depression and natural killer cells: potential clinical relevance. Clin Neuropharmacol. 1992; 15 Suppl 1 (Pt A):656A–657A.
   Google Scholar
• Evans DL, Leserman J, Pedersen CA, et al. Immune correlates of stress and depression. Psychopharmacol Bull. 1989;25:319–324.
   PubMedGoogle Scholar
• Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull. 1993;113:472–486.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Williams JB, Remien RH, Goetz R, Kertzner R, Gorman JM. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry. 1991;48:111–119.
   PubMed Web of Science ®Google Scholar
• Perry S, Fishman B, Jacobsberg L, Frances A. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry. 1992;49:396–401.
   PubMed Web of Science ®Google Scholar
• Barrett DC, Chesney MA, Burack JH, Stall RD, Ekstrand ML, Coates TJ. Depression and CD4 decline. JAMA. 1994;271:1743–1744.
   Web of Science ®Google Scholar
• Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568–2573.
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. JAMA. 1993;270:2563–2567.
   PubMed Web of Science ®Google Scholar
• Cruess DG, Petitto JM, Leserman J, et al. Depression and HIV infection: impact on immune function and disease progression. CNS Spectr. 2003;8:52–58.
   PubMed Web of Science ®Google Scholar
• Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends, 1991–1999. Am J Public Health. 2002;92:371–377.
   PubMed Web of Science ®Google Scholar
• Courtenay-Quirk C, Wolitski RJ, Parsons JT, Gomez CA. Is HIV/AIDS stigma dividing the gay community? Perceptions of HIV-positive men who have sex with men. AIDS Educ Prev. 2006;18:56–67.
   PubMed Web of Science ®Google Scholar
• Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care. 2009; 21:742–753.
   PubMed Web of Science ®Google Scholar
• Frost DM, Parsons JT, Nanin JE. Stigma, concealment and symptoms of depression as explanations for sexually transmitted infections among gay men. J Health Psychol. 2007;12:636–640.
   PubMed Web of Science ®Google Scholar
• Heckman TG, Heckman BD, Kochman A, Sikkema KJ, Suhr J, Goodkin K. Psychological symptoms among persons 50 years of age and older living with HIV disease. Aging Ment Health. 2002;6:121–128.
   PubMed Web of Science ®Google Scholar
• Robbins M, Szapocznik J, Tejeda M, Samuels D, Ironson G, Antoni M. The protective role of the family and social support network in a sample of HIV-positive African American women: results of a pilot study. J Black Psychol. 2003;29:17–37.
   PubMedGoogle Scholar
• Komiti A, Judd F, Grech P, et al. Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Aust N Z J Psychiatry. 2003;37:70–77.
   PubMed Web of Science ®Google Scholar
• Chenard C. The impact of stigma on the self-care behaviors of HIV-positive gay men striving for normalcy. J Assoc Nurses AIDS Care. 2007;18:23–32.
   PubMed Web of Science ®Google Scholar
• Kang E, Rapkin BD, Remien RH, Mellins CA, Oh A. Multiple dimensions of HIV stigma and psychological distress among Asians and Pacific Islanders living with HIV illness. AIDS Behav. 2005;9: 145–154.
   PubMed Web of Science ®Google Scholar
• Lichtenstein B. Stigma as a barrier to treatment of sexually transmitted infection in the American deep south: issues of race, gender and poverty. Soc Sci Med. 2003;57:2435–2445.
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
   PubMed Web of Science ®Google Scholar
• Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997;35:785–791.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41: 1284–1292.
   PubMed Web of Science ®Google Scholar
• Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42:1194–1201.
   PubMed Web of Science ®Google Scholar
• Dietrich AJ, Oxman TE, Williams JW Jr, et al. Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial. BMJ. 2004;329:602.
   PubMed Web of Science ®Google Scholar
• The MacArthur Initiative on Depression and Primary Care [homepage on the Internet]. MacArthur Foundation; c2003–2009. Available from: http://www.depression-primarycare.org/. Accessed 2010.
   Google Scholar
• Sharp LK, Lipsky MS. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician. 2002;66:1001–1008.
   PubMed Web of Science ®Google Scholar
• Caballero J, Nahata MC. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Ann Pharmacother. 2005;39:141–145.
   PubMed Web of Science ®Google Scholar
• Fulk LJ, Kane BE, Phillips KD, Bopp CM, Hand GA. Depression in HIV-infected patients: Allopathic, complementary, and alternative treatments. J Psychosom Res. 2004;57:339–351.
   PubMed Web of Science ®Google Scholar
• Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV-infected adults. AIDS. 2005;19:2057–2067.
   PubMed Web of Science ®Google Scholar
• Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry. 2003;54:307–316.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry. 1999;156:101–107.
   PubMed Web of Science ®Google Scholar
• Zisook S, Peterkin J, Goggin KJ, Sledge P,Atkinson JH, Grant I. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. J Clin Psychiatry. 1998;59:217–224.
   PubMed Web of Science ®Google Scholar
• Kumar AM, Fernandez J, Singer EJ, et al. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol. 2009;1–18.
   Web of Science ®Google Scholar
• Currier MB, Molina G, Kato M. A prospective prial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients. Psychosomatics. 2003;44:120–125.
   PubMed Web of Science ®Google Scholar
• Foisy M, Tseng A. Drug Interaction Tables. 2010. Toronto General Hospital. c 2010. Available from: http://www.hivclinic.ca/main/drugs_interact.html. Accessed 2010.
   Google Scholar
• Tseng AL, Foisy MM. Significant interactions with new antiretrovirals and psychotropic drugs. Ann Pharmacother. 1999;33:461–473.
   PubMed Web of Science ®Google Scholar
• Hesse LM, von Moltke LL, Shader RI, Greenblatt DJ. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. Drug Metab Dispos. 2001;29: 100–102.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Rabkin R, Wagner G. Testosterone replacement therapy in HIV illness. Gen Hosp Psychiatry. 1995;17:37–42.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry. 2000;57:141–147.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology. 2000;25:53–68.
   PubMed Web of Science ®Google Scholar
• Wagner GJ, Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial. J Clin Psychiatry. 2000;61:436–440.
   PubMed Web of Science ®Google Scholar
• Fernandez F, Levy JK, Samley HR, et al. Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine. Int J Psychiatry Med. 1995;25:53–67.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med. 2001;161:411–420.
   PubMedGoogle Scholar
• Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med. 1998;158:2257–2264.
   PubMed Web of Science ®Google Scholar
• Brown JL, Vanable PA. Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature. Ann Behav Med. 2008;35:26–40.
   PubMed Web of Science ®Google Scholar
• Himelhoch S, Medoff DR, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis. AIDS Patient Care STDS. 2007;21:732–739.
   PubMed Web of Science ®Google Scholar
• Ferrando SJ, Freyberg Z. Treatment of depression in HIV positive individuals: a critical review. Int Rev Psychiatry. 2008;20:61–71.
   PubMed Web of Science ®Google Scholar
• Safren SA, O’Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1–10.
   PubMed Web of Science ®Google Scholar
• Antoni MH, Carrico AW, Duran RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68:143–151.
   PubMed Web of Science ®Google Scholar
• Carrico AW, Antoni MH, Duran RE, et al. Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-Positive gay men treated with HAART. Ann Behav Med. 2006;31:155–164.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Cherry C, Cain D, et al. Internet-based health information consumer skills intervention for people living with HIV/AIDS. J Consult Clin Psychol. 2006;74:545–554.
   PubMed Web of Science ®Google Scholar
• Lai TY, Larson EL, Rockoff ML, Bakken S. User acceptance of HIV TIDES – Tailored Interventions for Management of Depressive Symptoms in persons living with HIV/AIDS. J Am Med Inform Assoc. 2008;15:217–226.
   PubMed Web of Science ®Google Scholar
• Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26:488–495.
   PubMed Web of Science ®Google Scholar